Your session is about to expire
← Back to Search
Cool Ropivacaine Block for Local Anesthesia
Phase 1
Waitlist Available
Led By Daniel Wambold, MD
Research Sponsored by Daniel Wambold
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 35 minutes
Awards & highlights
Study Summary
This trial is testing whether cooling the injected painkiller ropivacaine before surgery will prolong its pain-relieving effects, and thus reduce the amount of opioids needed afterwards.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 35 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~35 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time to block of pain and thermosensory perception
Secondary outcome measures
Morphine equivalency units of adjunct pain medications
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cool BlockExperimental Treatment1 Intervention
Ropivacaine administered at approximately 4C, via a TAP block.
Group II: Room Temp BlockActive Control1 Intervention
Ropivacaine administered at approximately 20-25C, via a TAP block.
Find a Location
Who is running the clinical trial?
Daniel WamboldLead Sponsor
Daniel Wambold, MDPrincipal InvestigatorUniversity of Kentucky
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger